191 related articles for article (PubMed ID: 20023890)
21. Synthetic strategies towards ruthenium-porphyrin conjugates for anticancer activity.
Gianferrara T; Bratsos I; Iengo E; Milani B; Ostrić A; Spagnul C; Zangrando E; Alessio E
Dalton Trans; 2009 Dec; (48):10742-56. PubMed ID: 20023904
[TBL] [Abstract][Full Text] [Related]
22. Anticancer metallotherapeutics in preclinical development.
Kaluderović GN; Paschke R
Curr Med Chem; 2011; 18(31):4738-52. PubMed ID: 21919843
[TBL] [Abstract][Full Text] [Related]
23. The prevalence of metal-based drugs as therapeutic or diagnostic agents: beyond platinum.
Gaynor D; Griffith DM
Dalton Trans; 2012 Nov; 41(43):13239-57. PubMed ID: 22930130
[TBL] [Abstract][Full Text] [Related]
24. A glycine ruthenium trithiacyclononane complex and its molecular encapsulation using cyclodextrins.
Marques J; Santos TM; Marques MP; Braga SS
Dalton Trans; 2009 Nov; (44):9812-9. PubMed ID: 19885528
[TBL] [Abstract][Full Text] [Related]
25. Platinum(II) complexes with l-methionylglycine and l-methionyl-l-leucine ligands: synthesis, characterization and in vitro antitumoral activity.
Kaluderović GN; Schmidt H; Paschke R; Kalinowski B; Dietrich A; Mueller T; Steinborn D
J Inorg Biochem; 2007 Mar; 101(3):543-9. PubMed ID: 17223197
[TBL] [Abstract][Full Text] [Related]
26. A categorization of metal anticancer compounds based on their mode of action.
Gianferrara T; Bratsos I; Alessio E
Dalton Trans; 2009 Oct; (37):7588-98. PubMed ID: 19759927
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic potential of coumarin bearing metal complexes: Where are we headed?
Balcıoğlu S; Olgun Karataş M; Ateş B; Alıcı B; Özdemir İ
Bioorg Med Chem Lett; 2020 Jan; 30(2):126805. PubMed ID: 31753700
[TBL] [Abstract][Full Text] [Related]
28. Multi-Target Metal-Based Anticancer Agents.
Chen ZF; Orvig C; Liang H
Curr Top Med Chem; 2017 Nov; 17(28):3131-3145. PubMed ID: 28982336
[TBL] [Abstract][Full Text] [Related]
29. DNA cleavage and antitumour activity of platinum(II) and copper(II) compounds derived from 4-methyl-2-N-(2-pyridylmethyl)aminophenol: spectroscopic, electrochemical and biological investigation.
Roy S; Maheswari PU; Lutz M; Spek AL; den Dulk H; Barends S; van Wezel GP; Hartl F; Reedijk J
Dalton Trans; 2009 Dec; (48):10846-60. PubMed ID: 20023915
[TBL] [Abstract][Full Text] [Related]
30. Cellular accumulation and DNA platination of two new platinum(II) anticancer compounds based on anthracene derivatives as carrier ligands.
Marqués-Gallego P; Kalayda GV; Jaehde U; Dulk Hd; Brouwer J; Reedijk J
J Inorg Biochem; 2009 May; 103(5):791-6. PubMed ID: 19303143
[TBL] [Abstract][Full Text] [Related]
31. Advances in cobalt complexes as anticancer agents.
Munteanu CR; Suntharalingam K
Dalton Trans; 2015 Aug; 44(31):13796-808. PubMed ID: 26148776
[TBL] [Abstract][Full Text] [Related]
32. Metal-based antitumour drugs in the post-genomic era: what comes next?
Sava G; Bergamo A; Dyson PJ
Dalton Trans; 2011 Sep; 40(36):9069-75. PubMed ID: 21725573
[TBL] [Abstract][Full Text] [Related]
33. Medicinal organometallic chemistry: designing metal arene complexes as anticancer agents.
Peacock AF; Sadler PJ
Chem Asian J; 2008 Nov; 3(11):1890-9. PubMed ID: 18712745
[TBL] [Abstract][Full Text] [Related]
34. Substituted beta-cyclodextrin and calix[4]arene as encapsulatory vehicles for platinum(II)-based DNA intercalators.
Krause-Heuer AM; Wheate NJ; Tilby MJ; Pearson DG; Ottley CJ; Aldrich-Wright JR
Inorg Chem; 2008 Aug; 47(15):6880-8. PubMed ID: 18597414
[TBL] [Abstract][Full Text] [Related]
35. NSAID-Based Coordination Compounds for Biomedical Applications: Recent Advances and Developments.
Santos ACF; Monteiro LPG; Gomes ACC; Martel F; Santos TM; Ferreira BJML
Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269997
[TBL] [Abstract][Full Text] [Related]
36. Synthesis, characterization, and cytotoxicity of dinuclear platinum-bisphosphonate complexes to be used as prodrugs in the local treatment of bone tumours.
Margiotta N; Ostuni R; Gandin V; Marzano C; Piccinonna S; Natile G
Dalton Trans; 2009 Dec; (48):10904-13. PubMed ID: 20023921
[TBL] [Abstract][Full Text] [Related]
37. Some uses of transition metal complexes as anti-cancer and anti-HIV agents.
Sun RW; Ma DL; Wong EL; Che CM
Dalton Trans; 2007 Nov; (43):4884-92. PubMed ID: 17992273
[TBL] [Abstract][Full Text] [Related]
38. Synthesis, characterization and cytotoxicity evaluation of some new platinum(II) complexes of tetrazolo[1,5-a]quinolines.
Bekhit AA; El-Sayed OA; Al-Allaf TA; Aboul-Enein HY; Kunhi M; Pulicat SM; Al-Hussain K; Al-Khodairy F; Arif J
Eur J Med Chem; 2004 Jun; 39(6):499-505. PubMed ID: 15183908
[TBL] [Abstract][Full Text] [Related]
39. Synthesis, characterization, DNA-binding study and anticancer properties of ternary metal(II) complexes of edda and an intercalating ligand.
Ng CH; Kong KC; Von ST; Balraj P; Jensen P; Thirthagiri E; Hamada H; Chikira M
Dalton Trans; 2008 Jan; (4):447-54. PubMed ID: 18185860
[TBL] [Abstract][Full Text] [Related]
40. Trapping unstable benzoquinone analogues by coordination to a [(η(5)-C(5)Me(5))Ir] fragment and the anticancer activity of the resulting complexes.
Hartinger CG
Angew Chem Int Ed Engl; 2010 Nov; 49(45):8304-5. PubMed ID: 20803595
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
